Drug intelligence / Profile preview

yiqi huoxue huaji decoction

Development stage: Unknown
Lead developer: Shenzhen Traditional Chinese Medicine Hospital
Administration: Oral

Overview

Yiqi Huoxue Huaji decoction is a Traditional Chinese Medicine (TCM) compound formulation developed by the Shenzhen Traditional Chinese Medicine Hospital. It is primarily indicated for the treatment of hepatitis B-related liver cirrhosis and severe liver fibrosis. The decoction is formulated based on the TCM principles of replenishing Qi (Yiqi), promoting blood circulation (Huoxue), and resolving masses (Huaji) to address 'zheng deficiency' syndromes. Research into the decoction utilizes multi-omics technologies to investigate its complex regulatory effects on gene expression and metabolic pathways, aiming to provide a scientific basis for its anti-fibrotic and hepatoprotective properties.

Other names: Yiqihuoxuehuaji decoctionYiqi Huoxue Huaji formula

Beyond the preview

Go deeper on yiqi huoxue huaji decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on yiqi huoxue huaji decoction.

Explore the full profile